Aquatic Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$585K Buy
6,080
+1,847
+44% +$185K 0.02% 709
2025
Q4
$412K Buy
4,233
+2,128
+101% +$183K 0.01% 797
2025
Q3
$150K Buy
2,105
+2,104
+210,400% +$140K ﹤0.01% 1139
2025
Q2
$60 Buy
+1
New +$55 ﹤0.01% 1208
2022
Q3
Sell
-100
Closed -$3K 1357
2022
Q2
$3K Buy
+100
New +$3.58K ﹤0.01% 1087
2022
Q1
Sell
-100
Closed -$5K 1286
2021
Q4
$5K Buy
+100
New +$4.03K 0.01% 946

Other funds holding IRMD

Aquatic Capital Management's IRMD Position: Q1 2026 in Review

Aquatic Capital Management increased its iRadimed (IRMD) stake by 44% in Q1 2026, buying an estimated $185K and bringing the position to 6,080 shares worth $585K. The position accounts for 0.02% of the portfolio, ranked #709.

Aquatic Capital Management first reported a position in IRMD in Q4 2021 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Aquatic Capital Management held 6,080 shares of iRadimed worth $585K as of Q1 2026.
  • Aquatic Capital Management bought 1,847 iRadimed shares in Q1 2026, an estimated $185K.
  • iRadimed made up 0.02% of Aquatic Capital Management's portfolio in Q1 2026, its #709 holding.
  • Aquatic Capital Management first reported a position in iRadimed in Q4 2021 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.